Monthly prophylactic injections of fitusiran are effective in reducing bleeds in patients with hemophilia A or B, according to randomized controlled trials publishing simultaneously in The Lancet and The Lancet Haematology ...
Mar 29, 2023
0
39
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG ...
Mar 9, 2023
0
31
Centenarians, once considered rare, have become commonplace. Indeed, they are the fastest-growing demographic group of the world's population, with numbers roughly doubling every ten years since the 1970s.
Oct 9, 2023
0
44
In children in the US and UK, a sudden increase in the number of cases of severe acute hepatitis of unknown causes (SAHUC) and pediatric acute liver failure was reported between October 2021 and May 2022. As of June 22, 2022, ...
Jul 19, 2022
0
16
In a consensus statement published online June 15 in JAMA Dermatology, data is provided for optimizing laboratory monitoring of acne patients treated with isotretinoin.
Jun 29, 2022
0
3
Patients with chronic liver disease may suffer hepatic complications as a result of severe COVID-19. A study conducted by a research team led by Lukas Hartl, Thomas Reiberger and Michael Trauner from the Division of Gastroenterology ...
Jun 15, 2022
0
88
(HealthDay)—A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the ...
Feb 14, 2022
0
20
(HealthDay)—From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) among children, although many still remain undiagnosed, according to a study published online Nov. 19 in ...
Nov 19, 2020
0
2
(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and Drug Administration announced.
Aug 5, 2019
0
3
(HealthDay)—The risk of stillbirth is increased in women with intrahepatic cholestasis of pregnancy when serum bile acids concentrations are ≥100 µmol/L or more, according to a review published in the March 2 issue of ...
Mar 13, 2019
0
4
